M&A Deal Summary

Vesey Street Capital Partners Acquires Inceptua

On January 16, 2024, private equity firm Vesey Street Capital Partners acquired life science company Inceptua

Acquisition Highlights
  • This is Vesey Street Capital Partners’ 2nd transaction in the Life Science sector.
  • This is Vesey Street Capital Partners’ 1st transaction in Luxembourg.

M&A Deal Summary
Date 2024-01-16
Target Inceptua
Sector Life Science
Buyer(s) Vesey Street Capital Partners
Deal Type Recapitalization

Target

Inceptua

Luxembourg, Luxembourg
Inceptua is a global pharmaceutical services company with capabilities across multiple business areas. Inceptua Clinical Trial Supply provides clinical trial supply, services and logistics, including comparator sourcing of medicines, packaging, labelling, storage, and distribution services. Inceptua Early Access offers strategic advice, design, facilitation, and implementation of global early access programs, and distributes unlicensed and other medicines worldwide. Inceptua is based in Luxembourg.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Vesey Street Capital Partners

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2014
PE ASSETS 600M USD
Size Middle-Market
Type Sector Focused
DESCRIPTION

Vesey Street Capital Partners is a specialist private equity firm focused on the healthcare sector. Vesey Street specializes in middle-market buyouts and growth equity investments, and seeks companies with $10 to $20 million of EBITDA. Target businesses generally exhibit strong cash flow characteristics that create value for hospitals and physicians by enhancing efficiency, improving quality, reducing costs, and expanding revenues. Vesey Street Capital Partners was formed in 2014 and is based in New York, New York.

DEAL STATS #
Overall 9 of 9
Sector (Life Science) 2 of 2
Type (Recapitalization) 7 of 7
Country (Luxembourg) 1 of 1
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-08-18 QualityMetric

Johnston, Rhode Island, United States

QualityMetric works with healthcare and life sciences companies to measure and better understand outcomes through the creation, administration, and review of general and patient-specific health surveys. QualityMetric combines its proprietary scientifically validated general health and disease-specific surveys with its enabling technology, advanced analytics, and sector expertise to work with all the world's largest pharmaceutical companies in clinical trials and patient surveillance. QualityMetric was founded in 1997 and is based in Johnston, Rhode Island.

Sell -
Mergr

Product

Company

Legal